Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,702,900 | 2,999,000 | 1,392,600 | 5,888,500 | 4,448,800 |
| Depreciation Amortization | 366,800 | 232,800 | 119,900 | 680,600 | 567,600 |
| Income taxes - deferred | 211,900 | 180,200 | 36,900 | 67,100 | 28,400 |
| Accounts receivable | -135,700 | -268,800 | -238,400 | 68,800 | -2,400 |
| Other Working Capital | -52,100 | -234,800 | -327,900 | 199,300 | -60,600 |
| Other Operating Activity | 503,100 | 507,400 | 484,200 | 174,300 | 136,600 |
| Operating Cash Flow | $4,596,900 | $3,415,800 | $1,467,300 | $7,078,600 | $5,118,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -338,800 | -254,700 | -149,700 | -514,500 | -404,100 |
| Net Acquisitions | -565,500 | -141,800 | N/A | -120,700 | 623,700 |
| Purchase Of Investment | -4,649,100 | -3,753,900 | -1,684,700 | -5,252,600 | -4,052,100 |
| Sale Of Investment | 5,241,200 | 3,880,400 | 2,389,800 | 6,486,300 | 4,343,600 |
| Purchase Sale Intangibles | -112,000 | -112,000 | -112,000 | -155,000 | -744,400 |
| Other Investing Activity | -130,000 | -119,800 | -112,500 | -128,000 | -749,000 |
| Investing Cash Flow | $-442,200 | $-389,800 | $442,900 | $470,500 | $-237,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,467,300 | 1,467,300 | N/A | N/A | 0 |
| Common Stock Issued | N/A | -19,200 | N/A | N/A | -16,900 |
| Common Stock Repurchased | -6,279,100 | -5,029,100 | -2,249,800 | -5,868,300 | -3,775,200 |
| Other Financing Activity | -59,800 | 22,300 | 4,500 | 7,900 | 48,100 |
| Financing Cash Flow | $-4,871,600 | $-3,558,700 | $-2,245,300 | $-5,860,400 | $-3,744,000 |
| Exchange Rate Effect | 28,000 | 3,900 | 12,700 | 400 | -17,200 |
| Beginning Cash Position | 2,913,700 | 2,913,700 | 2,913,700 | 1,224,600 | 1,224,600 |
| End Cash Position | 2,224,800 | 2,384,900 | 2,591,300 | 2,913,700 | 2,343,900 |
| Net Cash Flow | $-688,900 | $-528,800 | $-322,400 | $1,689,100 | $1,119,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,596,900 | 3,415,800 | 1,467,300 | 7,078,600 | 5,118,400 |
| Capital Expenditure | -338,800 | -254,700 | -149,700 | -514,500 | -404,100 |
| Free Cash Flow | 4,258,100 | 3,161,100 | 1,317,600 | 6,564,100 | 4,714,300 |